| Literature DB >> 26484116 |
Alan T Branco1, Bernardo Lemos1.
Abstract
Human exposure to environmental toxins is a public health issue. The microarray data available in the Gene Expression Omnibus database under accession number GSE55655 and GSE55670GSE55655GSE55670 show the isolated and combined effects of dietary sugar and two organic compounds present in a variety of plastics [bisphenol A (BPA) and Bis(2-ethylhexyl) phthalate (DEHP)] on global gene expression in Drosophila melanogaster. The study was carried out with samples collected from flies exposed to these compounds for a limited period of time (48 h) in the adult stage, or throughout the entire development of the insect. The arrays were normalized using the limma/Bioconductor package. Differential expression was inferred using linear models in limma and BAGEL. The data show that each compound had its unique consequences to gene expression, and that the individual effect of each organic compound is maximized with the joint ingestion of dietary sugar.Entities:
Keywords: BPA; Bisphenol A; DEHP; Drosophila; Sugar
Year: 2014 PMID: 26484116 PMCID: PMC4535756 DOI: 10.1016/j.gdata.2014.09.005
Source DB: PubMed Journal: Genom Data ISSN: 2213-5960
Experimental contrasts with corresponding files deposited in the GEO data bank.
| File | Dye | Sample | Treatment | N° of detected spots | N° of spots after QC |
|---|---|---|---|---|---|
| 24.gpr | Cy5 | Control “B” (Rep. 1) | Chronic exposure | 7916 | 4013 |
| Cy3 | Control “A” (Rep. 1) | ||||
| 25.gpr | Cy5 | BPA “B” (Rep. 1) | Chronic exposure | 7859 | 3856 |
| Cy3 | Control “A” (Rep. 2) | ||||
| 26.gpr | Cy5 | Control “A” (Rep. 1) | Chronic exposure | 8521 | 4618 |
| Cy3 | High sugar “B” (Rep. 1) | ||||
| 27.gpr | Cy5 | Control “A” (Rep. 2) | Chronic exposure | 7541 | 3646 |
| Cy3 | BPA + high sugar “B” (Rep. 1) | ||||
| 34.gpr | Cy5 | BPA + high sugar “A” (Rep. 1) | Chronic exposure | 9810 | 6552 |
| Cy3 | Control “B” (Rep. 1) | ||||
| 35.gpr | Cy5 | BPA “A” (Rep. 1) | Chronic exposure | 10,023 | 6226 |
| Cy3 | Control “B” (Rep. 2) | ||||
| 36.gpr | Cy5 | BPA “B” (Rep. 2) | Chronic exposure | 9837 | 6426 |
| Cy3 | BPA “A” (Rep. 1) | ||||
| 37.gpr | Cy5 | BPA + high sugar “A” (Rep. 2) | Chronic exposure | 9963 | 5933 |
| Cy3 | BPA “B” (Rep. 2) | ||||
| 38.gpr | Cy5 | Control “B” (Rep. 2) | Chronic exposure | 10,427 | 6300 |
| Cy3 | High sugar “A” (Rep. 2) | ||||
| 39.gpr | Cy5 | High sugar “B” (Rep. 3) | Chronic exposure | 9205 | 5811 |
| Cy3 | High sugar “A” (Rep. 1) | ||||
| 40.gpr | Cy5 | High sugar “B” (Rep. 3) | Chronic exposure | 9450 | 5625 |
| Cy3 | BPA + high sugar “A” (Rep. 1) | ||||
| 41.gpr | Cy5 | BPA “A” (Rep. 1) | Chronic exposure | 8937 | 5076 |
| Cy3 | High sugar “B” (Rep. 2) | ||||
| 42.gpr | Cy5 | High sugar “A” (Rep. 1) | Chronic exposure | 9507 | 5283 |
| Cy3 | BPA + high sugar “B” (Rep. 2) | ||||
| 43.gpr | Cy5 | High sugar “A” (Rep. 2) | Chronic exposure | 9338 | 5135 |
| Cy3 | BPA “B” (Rep. 1) | ||||
| 44.gpr | Cy5 | BPA + high sugar “B” (Rep. 1) | Chronic exposure | 9310 | 5185 |
| Cy3 | BPA “A” (Rep. 2) | ||||
| 45.gpr | Cy5 | BPA + high sugar “B” (Rep. 2) | Chronic exposure | 8671 | 4661 |
| Cy3 | BPA + high sugar “A” (Rep. 2) | ||||
| 61.gpr | Cy5 | DEHP (Rep. 1) | Acute exposure | 12,026 | 7505 |
| Cy3 | Control (Rep. 1) | ||||
| 62.gpr | Cy5 | High sugar (Rep. 2) | Acute exposure | 12,464 | 8403 |
| Cy3 | DEHP (Rep. 2) | ||||
| 63.gpr | Cy5 | BPA + DEHP + High sugar (Rep. 2) | Acute exposure | 12,492 | 7762 |
| Cy3 | High sugar (Rep. 1) | ||||
| 64.gpr | Cy5 | BPA (Rep. 2) | Acute exposure | 11,555 | 7056 |
| Cy3 | BPA + DEHP + high sugar (Rep. 1) | ||||
| 65.gpr | Cy5 | Control (Rep. 2) | Acute exposure | 11,642 | 6913 |
| Cy3 | BPA (Rep. 1) | ||||
| 66.gpr | Cy5 | Control (Rep. 1) | Acute exposure | 11,936 | 6894 |
| Cy3 | High sugar (Rep. 2) | ||||
| 67.gpr | Cy5 | DEHP (Rep. 2) | Acute exposure | 12,768 | 8254 |
| Cy3 | BPA + DEHP + high sugar (Rep. 2) | ||||
| 68.gpr | Cy5 | High sugar (Rep. 1) | Acute exposure | 11,367 | 1999 |
| Cy3 | BPA (Rep. 2) | ||||
| 69.gpr | Cy5 | BPA (Rep. 1) | Acute exposure | 11,963 | 7327 |
| Cy3 | DEHP (Rep. 1) | ||||
| 70.gpr | Cy5 | BPA + DEHP + high sugar (Rep. 1) | Acute exposure | 11,884 | 6485 |
| Cy3 | Control (Rep. 2) |
“Rep” stands for “Replicate”, and denotes the sample used in the hybridization contrast.
“A” and “B” represent, respectively, the genotypes Yohio and Ycongo. Noteworthy, acute exposure was carried out only with the Yohio genotype.
Expression data from chronic and acute exposures were deposited in the GEO data bank, respectively, as GSE55670 and GSE55655GSE55670GSE55655.
Number of genes displaying fluorescence above background in each microarray slide.
Number of spots after exclusion of bad quality spots according to the rule for quality control (QC) described in the topic “Microarray analysis”. These spots were used for further analysis of differential expression.
Fig. 1Schematic representation of cDNA hybridizations. The figure shows the contrast of each microarray slide carried out for acute (A) and chronic (B) exposures. The arrows symbolize each hybridization, in which, the arrow 's head indicates the sample probed with Cy5 and the base of it the sample labeled with Cy3 (See Table 1 for details). Black boxes indicate the .gpr files associated with the comparison and publicly available in the Gene Expression Omnibus database. Acute Exposure was carried out only with the Yohio genotype.
| Organism/cell line/tissue | |
| Sex | Male |
| Sequencer or array type | 22,000-feature custom cDNA array |
| Data format | Raw data: GPR file; normalized data: SOFT |
| Experimental factors | Acute and chronic exposures to BPA, DEHP, sugar |
| Experimental features | Global transcription analysis of fruit flies exposed to medium containing BPA, DEHP, sugar, or a mixture of these compounds. Exposure was done in adult flies for 48 h, or throughout the insect development |
| Consent | NA |
| Sample source location | Samples obtained from Bloomington Drosophila Stock Center at Indiana University and maintained in laboratory conditions at Harvard School of Public Health–Boston–USA |